Skip to main content
Clinical Trials/NL-OMON20942
NL-OMON20942
Completed
Not Applicable

Prospective Assessment of Risk Factors for Appropriate ICD Intervention in Patients with Ischemic Cardiomyopathy.

BIOTRONIK SE & Co. KGWoermannkehre 1D - 12359 BerlinGermany0049 (0)30 689-0500 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ischemische cardiomyopathie, hartfalenischemic cardiomypathy, heart failure
Sponsor
BIOTRONIK SE & Co. KGWoermannkehre 1D - 12359 BerlinGermany0049 (0)30 689-050
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
BIOTRONIK SE & Co. KGWoermannkehre 1D - 12359 BerlinGermany0049 (0)30 689-050

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient with ischemic cardiomyopathy indicated for a de novo ICD implantation for primary prevention, according to ESC guidelines or local standards (MADIT II population);
  • 2\. Written informed consent / willingness and ability to comply with the protocol.

Exclusion Criteria

  • 1\. Contraindication for MRI;
  • 2\. Severe renal dysfunction (stage 4 or 5\) resulting in contra\-indication for the admission of gadolinium during MRI;

Outcomes

Primary Outcomes

Not specified

Similar Trials